| Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests KA Bates, G Verdile, QX Li, D Ames, P Hudson, CL Masters, RN Martins Molecular psychiatry 14 (5), 469-486, 2009 | 304 | 2009 |
| Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests KA Bates, G Verdile, QX Li, D Ames, P Hudson, CL Masters, RN Martins Molecular psychiatry 14 (5), 469-486, 2009 | 304 | 2009 |
| Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology H Scholtzova, RJ Kascsak, KA Bates, A Boutajangout, DJ Kerr, ... Journal of Neuroscience 29 (6), 1846-1854, 2009 | 193 | 2009 |
| Olfactory discrimination predicts cognitive decline among community-dwelling older adults HR Sohrabi, KA Bates, MG Weinborn, ANB Johnston, A Bahramian, ... Translational psychiatry 2 (5), e118-e118, 2012 | 130 | 2012 |
| Loss of the RNA-binding protein TACO1 causes late-onset mitochondrial dysfunction in mice TR Richman, H Spåhr, JA Ermer, SMK Davies, HM Viola, KA Bates, ... Nature communications 7 (1), 11884, 2016 | 90 | 2016 |
| Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases PR Bharadwaj, KA Bates, T Porter, E Teimouri, G Perry, JW Steele, ... Translational psychiatry 3 (12), e332-e332, 2013 | 89 | 2013 |
| Chronic gliosis triggers Alzheimer’s disease-like processing of amyloid precursor protein KA Bates, J Fonte, TA Robertson, RN Martins, AR Harvey Neuroscience 113 (4), 785-796, 2002 | 67 | 2002 |
| Androgens, andropause and neurodegeneration: exploring the link between steroidogenesis, androgens and Alzheimer’s disease KA Bates, AR Harvey, M Carruthers, RN Martins Cell Mol Life Sci 62 (3), 281-292, 2005 | 59 | 2005 |
| Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals HR Sohrabi, KA Bates, M Rodrigues, K Taddei, SM Laws, ... Journal of Alzheimer's Disease 17 (1), 135-142, 2009 | 54 | 2009 |
| Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice J Yang, Y Ji, P Mehta, KA Bates, Y Sun, T Wisniewski Journal of Alzheimer's Disease 24 (2), 269-285, 2011 | 53 | 2011 |
| Immunization in Alzheimer's disease: naive hope or realistic clinical potential? JK Foster, G Verdile, KA Bates, RN Martins Molecular psychiatry 14 (3), 239-251, 2009 | 52 | 2009 |
| Association of cardiovascular factors and Alzheimer's disease plasma amyloid-β protein in subjective memory complainers KA Bates, HR Sohrabi, M Rodrigues, J Beilby, SS Dhaliwal, K Taddei, ... Journal of Alzheimer's Disease 17 (2), 305-318, 2009 | 50 | 2009 |
| Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women KA Bates, HR Sohrabi, SR Rainey-Smith, M Weinborn, RS Bucks, ... International Journal of Neuroscience 127 (3), 243-252, 2017 | 49 | 2017 |
| Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue RN Martins, K Taddei, C Kendall, G Evin, KA Bates, AR Harvey Neuroscience 106 (3), 557-569, 2001 | 47 | 2001 |
| The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Eε4 carriers and non-carriers HR Sohrabi, KA Bates, M Rodrigues, K Taddei, G Martins, SM Laws, ... Journal of Alzheimer's Disease 17 (1), 69-79, 2009 | 43 | 2009 |
| Effect of chronic hCG administration on Alzheimer’s-related cognition and Aβ accumulation in PS1KI mice AM Barron, G Verdile, K Taddei, KA Bates, RN Martins Endocrinology 151 (11), 5380-5388, 2010 | 40 | 2010 |
| Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEε4 carriers in the Australian population M Rimajova, NP Lenzo, JS Wu, KA Bates, A Campbell, SS Dhaliwal, ... Journal of Alzheimer's disease 13 (2), 137-146, 2008 | 39 | 2008 |
| Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-β levels EJ Wahjoepramono, LK Wijaya, K Taddei, G Martins, M Howard, ... Journal of Alzheimer's Disease 15 (1), 129-137, 2008 | 35 | 2008 |
| Repetitive transcranial magnetic stimulation for stroke rehabilitation-potential therapy or misplaced hope? KA Bates, J Rodger Restorative Neurology and Neuroscience 33 (4), 557-569, 2015 | 33 | 2015 |
| Protein markers for Alzheimer disease in the frontal cortex and cerebellum G Verdile, A Gnjec, J Miklossy, J Fonte, G Veurink, K Bates, B Kakulas, ... Neurology 63 (8), 1385-1392, 2004 | 33 | 2004 |
